Back to Search

MAANASI SAMANT, MD

MD

Pulmonary Disease Physician

NPI: 1427463074IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine Physician

Internal Medicine

Code: 207R00000X

2018007773(MO)
Critical Care Medicine (Internal Medicine) Physician

Internal Medicine — Critical Care Medicine

Code: 207RC0200X

2018007773(MO)
Pulmonary Disease PhysicianPrimary

Internal Medicine — Pulmonary Disease

Code: 207RP1001X

2018007773(MO)036157776(IL)

CMS Specialties

PrimaryPULMONARY DISEASE

Additional

CRITICAL CARE (INTENSIVISTS)INTERNAL MEDICINE

Education

UNIVERSITY OF TENNESSEE, HSC, COLLEGE OF MEDICINE

Class of 2014

Research & Publications (20)

Totally tubeless outpatient percutaneous nephrolithotomy: initial case report.
PMID 19478955·Adv Urol·2009
5-case
Retrospective evaluation of the clinical and radiographic risk factors associated with severe pulmonary hemorrhage in first-line advanced, unresectable non-small-cell lung cancer treated with Carboplatin and Paclitaxel plus bevacizumab.
PMID 19224857·J Clin Oncol·2009
3-trial
Role of confocal microscopy in deep fungal keratitis.
PMID 19092397·Cornea·2009
8-other
Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis.
PMID 19053149·Eur J Immunol·2009
7-preclinical
Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis.
PMID 19542458·J Immunol·2009
7-preclinical
Ring size of somatostatin analogues (ODT-8) modulates receptor selectivity and binding affinity.
PMID 18410084·J Med Chem·2008
7-preclinical
Evaluation of antileishmanial potential of Tinospora sinensis against experimental visceral leishmaniasis.
PMID 18080140·Parasitol Res·2008
7-preclinical
Ring size in octreotide amide modulates differently agonist versus antagonist binding affinity and selectivity.
PMID 18410083·J Med Chem·2008
8-other
Discovery of novel vaccine candidates and drug targets against visceral leishmaniasis using proteomics and transcriptomics.
PMID 18991606·Curr Drug Targets·2008
6-review
Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.
PMID 18762224·Vaccine·2008
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
676 N SAINT CLAIR ST STE 2100
CHICAGO, IL 60611

Locations (2)

Practice Location

676 N SAINT CLAIR ST STE 2100, CHICAGO, IL
(312) 695-1800

Practice Location

4921 PARKVIEW PL, SAINT LOUIS, MO
(314) 454-8917

Quick Facts

NPI
1427463074
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
4
Locations
2
Years in Practice
12
Publications
20

Are you this provider?

Claim Your Profile